Geovax Labs Inc Quick Ratio (GOVX) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Geovax Labs Inc   (NASDAQ: GOVX)

Geovax Labs Inc 's Quick Ratio

GOVX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Geovax Labs Inc 's Cash & cash equivalent grew by 148.74 % in the Q2 2026 sequentially, faster than Current Liabilities, this led to improvement in Geovax Labs Inc 's Quick Ratio to 1.17, Quick Ratio remained below Geovax Labs Inc average.

Within Major Pharmaceutical Preparations industry 335 other companies have achieved higher Quick Ratio than Geovax Labs Inc in second quarter 2026. While Quick Ratio total ranking has improved so far during the Q2 2026 to 1673, from total ranking in the first quarter 2026 at 2070.

Explain Quick Ratio?
How much Cash & cash equivalents GOVX´s has?
What are GOVX´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GOVX Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 7.25 % -21.93 % -37.67 % -30.06 % -60.51 %
Y / Y Cash & cash equivalent Change 2.25 % -82.9 % -43.97 % -41.71 % 98.11 %
Quick Ratio MRQ 1.17 0.55 1.59 2.75 1.22
GOVX's Total Ranking # 1673 # 2070 # 1413 # 848 # 54
Seq. Current Liabilities Change 18.37 % 18.32 % 6.17 % -27.88 % -13.84 %
Seq. Cash & cash equivalent Change 148.74 % -58.79 % -38.4 % 61.9 % -58.41 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 336
Healthcare Sector # 600
Overall Market # 1673


Quick Ratio Statistics
High Average Low
54.45 6.86 0.09
(Jun 30 2021)   (Mar 31 2020)




Financial Statements
Geovax Labs Inc 's Current Liabilities $ 3 Millions Visit GOVX's Balance sheet
Geovax Labs Inc 's Cash & cash equivalent $ 3 Millions Visit GOVX's Balance sheet
Source of GOVX's Sales Visit GOVX's Sales by Geography


Cumulative Geovax Labs Inc 's Quick Ratio

GOVX's Quick Ratio for the trailling 12 Months

GOVX Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -21.6 % -43 % -40.19 % -34.35 % -44.95 %
Y / Y Cash & cash equivalent TTM Growth -49.13 % -46.06 % 13.37 % 21.06 % 14.67 %
Quick Ratio TTM 1.43 1.45 2.02 2.02 2.2
Total Ranking TTM # 3925 # 3919 # 3019 # 3118 # 222
Seq. Current Liabilities TTM Growth 2.14 % -6.98 % -11.26 % -7.01 % -25.74 %
Seq. Cash & cash equivalent TTM Growth 0.56 % -33.11 % -11.5 % -14.55 % 6.63 %

Quick ratio ranking by company, industry and sector >> Back to GOVX Financial Strength Comparisons >> Go to Compare GOVX Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q2 2026 to $2.71 millions, cumulative Quick Ratio decreased to 1.43 below the Geovax Labs Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 430 other companies have achieved higher Quick Ratio than Geovax Labs Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3919 to 3925.

Explain Quick Ratio?
How much Cash & cash equivalents GOVX´s has?
What are GOVX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 431
Healthcare Sector # 886
Within the Market # 3925


trailing twelve months Quick Ratio Statistics
High Average Low
34.96 4.56 0.16
(Sep 30 2021)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Major Pharmaceutical Preparations Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Harmony Biosciences Holdings inc   3.17 $ 667.791  Millions$ 210.812  Millions
Pulmatrix Inc   3.15 $ 2.168  Millions$ 0.689  Millions
Nextcure Inc   3.13 $ 20.088  Millions$ 6.413  Millions
Dianthus Therapeutics Inc   3.13 $ 107.611  Millions$ 34.389  Millions
Tg Therapeutics Inc   3.02 $ 811.665  Millions$ 268.493  Millions
Dermata Therapeutics Inc   3.02 $ 4.413  Millions$ 1.462  Millions
Xilio Therapeutics Inc   2.99 $ 136.040  Millions$ 45.487  Millions
Cadrenal Therapeutics Inc  2.99 $ 4.476  Millions$ 1.497  Millions
Zevra Therapeutics Inc   2.99 $ 145.321  Millions$ 48.632  Millions
Inhibitor Therapeutics Inc   2.95 $ 0.516  Millions$ 0.175  Millions
Annovis Bio Inc   2.95 $ 18.736  Millions$ 6.359  Millions
Puma Biotechnology Inc   2.89 $ 144.164  Millions$ 49.825  Millions
Ptc Therapeutics inc   2.89 $ 2,229.082  Millions$ 771.068  Millions
Werewolf Therapeutics Inc   2.80 $ 21.987  Millions$ 7.863  Millions
Alzamend Neuro Inc   2.77 $ 7.591  Millions$ 2.739  Millions
Scienture Holdings Inc   2.71 $ 8.188  Millions$ 3.026  Millions
Acadia Pharmaceuticals Inc   2.65 $ 956.474  Millions$ 361.436  Millions
Edesa Biotech Inc   2.63 $ 10.300  Millions$ 3.910  Millions
Hepion Pharmaceuticals Inc   2.63 $ 1.629  Millions$ 0.620  Millions
Stoke Therapeutics Inc   2.62 $ 110.004  Millions$ 41.930  Millions
Elicio Therapeutics Inc   2.55 $ 23.480  Millions$ 9.202  Millions
Adc Therapeutics Sa  2.54 $ 219.107  Millions$ 86.332  Millions
Beone Medicines Ltd   2.50 $ 5,290.368  Millions$ 2,119.187  Millions
Ironwood Pharmaceuticals inc   2.41 $ 79.127  Millions$ 32.854  Millions
Schrodinger Inc   2.38 $ 413.739  Millions$ 173.845  Millions
Insmed Inc  2.37 $ 1,160.312  Millions$ 490.508  Millions
Biovie Inc   2.37 $ 8.977  Millions$ 3.796  Millions
Tao Synergies Inc   2.30 $ 2.368  Millions$ 1.032  Millions
Madrigal Pharmaceuticals Inc   2.24 $ 839.419  Millions$ 374.204  Millions
Rockwell Medical inc   2.23 $ 24.936  Millions$ 11.174  Millions

Date modified: 2026-07-28T05:36:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.